Kerry A Rogers

Dr. Kerry A. Rogers is an Associate Professor in the Division of Hematology at The Ohio State University, where she specializes in chronic lymphocytic leukemia (CLL). In the discussion, she outlines the latest treatment options, comparing continuous BTK inhibitors with venetoclax-based therapies. Dr. Rogers shares insights on emerging agents, including sonrotoclax and pirtobrutinib, and emphasizes the importance of MRD testing. She also presents case studies that highlight personalized treatment strategies depending on patient profiles and comorbidities.